SAREPTA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.8 USD | -0.36% |
|
-1.38% | +36.70% |
Chart calendar Sarepta Therapeutics, Inc.
fd7dd1ee6e590f6f32.UeD-c8NWYE458uDVP-NO1R1CUrn_B0P1LaG3Zy8zOfE.JbmKS64UMzhXos2iXpAZkHUVC9-yNm7FANuaBWZSTrcEjbkruTVTGlG01A~0b2b99782cc12625c617a7d13ea0b99c
Upcoming events on Sarepta Therapeutics, Inc.
Past events on Sarepta Therapeutics, Inc.
| 2024-05-01 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-01 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-12 03:05 pm | Barclays Global Healthcare Conference |
| 2024-03-11 10:00 am | Leerink Partners Global Biopharma Conference |
| 2024-02-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-28 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-29 08:30 am | SRP-5051-201 Phase 2 Part B Study Results Call |
| 2024-01-29 08:30 am | SRP-5051-201 Phase 2 Part B Study Results Call |
| 2024-01-08 12:00 pm | JPMorgan Healthcare Conference |
| 2023-11-09 09:00 am | UBS BioPharma Conference |
| 2023-11-01 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-01 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-30 04:30 pm | Business Update Call |
| 2023-09-11 08:40 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-02 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-02 04:05 pm | Q2 2023 Earnings Release |
| 2023-07-10 11:00 am | Cowen RNA Therapeutics Summit |
| 2023-06-22 04:30 pm | ELEVIDYS FDA Approval Call |
| 2023-06-08 10:00 am | Annual General Meeting |
| 2023-05-02 04:30 pm | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 381 379 0.54% | 540 537 0.61% | 702 689 1.8% | 933 925 0.86% | 1 243 1 233 0.87% | 1 898 |
|
EBITDA Million USD | Released Forecast Spread | -681 -596 -14.33% | -537 -535 -0.4% | -422 -479 11.97% | -494 -518 4.49% | -223 -278 19.63% | 198 |
|
EBIT Million USD | Released Forecast Spread | -706 -611 -15.49% | -564 -518 -8.89% | -460 -460 -0.03% | -536 -517 -3.66% | -268 -303 11.68% | 252 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -714 -618 -15.52% | -553 -522 -6% | -419 -433 3.28% | -690 -708 2.57% | -520 -559 6.94% | 240 |
|
Net income Million USD | Released Forecast Spread | -715 -617 -15.85% | -554 -519 -6.72% | -419 -438 4.35% | -703 -677 -3.95% | -536 -579 7.41% | 266 |
|
EPS USD | Released Forecast Spread | -9,71 -8,44 -15.05% | -7,11 -6,66 -6.71% | -5,15 -5,20 0.98% | -8,03 -7,54 -6.49% | -5,80 -6,39 9.19% | 3,23 |
| Announcement Date | 26/02/20 | 01/03/21 | 01/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 211 208 1.24% | 233 221 5.56% | 230 235 -1.83% | 258 251 3.16% | 254 241 4.98% | 261 262 -0.36% | 332 287 15.71% | 397 386 2.75% | 413 375 10.13% | 379 | 498 | 583 | 591 | 653 |
|
EBITDA Million USD | Released Forecast Spread | 71,6 | 122 | 215 | |||||||||||
|
EBIT Million USD | Released Forecast Spread | -86,9 -109 20.02% | -211 -92,7 -127.71% | -131 -112 -17.53% | -107 -105 -1.92% | -138 -116 -19.22% | -134 -169 21.04% | -20,8 -120 82.64% | 24,6 -7,43 431.59% | 34,9 -18,3 290.45% | -22,6 | 90,4 | 167 | 172 | 234 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -104 -115 9.58% | -228 -99,6 -128.92% | -256 -132 -93.89% | -101 -115 11.92% | -513 -129 -298.57% | -14,6 -156 90.67% | -33,2 -105 68.47% | 40,4 4,23 854.54% | 41,4 -12,3 436.79% | -13,6 | 101 | 186 | 174 | 239 |
|
Net income Million USD | Released Forecast Spread | -105 -118 10.76% | -231 -101 -129.34% | -258 -122 -111.7% | -109 -103 -6.06% | -517 -116 -343.89% | -23,9 -164 85.42% | -40,9 -115 64.4% | 45,7 -5,49 931.45% | 36,1 -3,63 1094.49% | -4,21 | 93,6 | 181 | 170 | 234 |
|
EPS USD | Released Forecast Spread | -1,20 -1,35 11.25% | -2,65 -1,15 -130.76% | -2,94 -1,41 -109.25% | -1,24 -1,18 -5.21% | -5,86 -1,29 -353.43% | -0,27 -1,80 85.01% | -0,46 -1,26 63.38% | 0,47 -0,05 1083.47% | 0,37 0,02 2366.67% | 0,00 | 0,97 | 1,81 | 1,35 | 2,17 |
| Announcement Date | 04/05/22 | 02/08/22 | 02/11/22 | 28/02/23 | 02/05/23 | 02/08/23 | 01/11/23 | 28/02/24 | 01/05/24 | - | - | - | - | - |
More events
Past sector events for Sarepta Therapeutics, Inc.
| 2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:15 pm | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:10 pm | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:09 pm | XENCOR, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SRPT Stock
- Calendar Sarepta Therapeutics, Inc.